Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia.
about
Botulinum toxin type B for cervical dystoniaBotulinum toxin type B for cervical dystoniaBotulinum toxinConsiderations on patient-related outcomes with the use of botulinum toxins: is switching products safe?Botulinum toxin injections for treating neurogenic detrusor overactivityClinical relevance of botulinum toxin immunogenicityCurrent and future medical treatment in primary dystonia.Treatment of dystonia.Botulinum B treatment of the glabellar and frontalis regions: a dose response analysis.Use of botulinum toxin in pediatric spasticity (cerebral palsy).Efficacy of pharmacological treatment of dystonia: evidence-based review including meta-analysis of the effect of botulinum toxin and other cure options.Botulinum toxins types A and B for brow furrows: preliminary experiences with type B toxin dosing.Spasticity management: an overview.Severity and impact of xerostomia in patients treated with botulinum toxin type b for cervical dystonia: Observations on the quality of life of patients with xerostomia.RimabotulinumtoxinB in sialorrhea: systematic review of clinical trialsBotulinum neurotoxin D-C uses synaptotagmin I and II as receptors, and human synaptotagmin II is not an effective receptor for type B, D-C and G toxins.Pre-operative evaluations for DBS in dystonia.Pharmacotherapy with botulinum toxin: harnessing nature's most potent neurotoxin.PEG precipitation coupled with chromatography is a new and sufficient method for the purification of botulinum neurotoxin type B [corrected].Dystonia rating scales: critique and recommendationsThe safety and tolerability of botulinum toxins for the treatment of cervical dystonia.Botulinum toxin type B: a new injectable treatment for cervical dystonia.Focal dystonia: the role of botulinum toxin.Clinical presentation and management of antibody-induced failure of botulinum toxin therapy.Treatment of cervical dystonia with botulinum toxin.Botulinum toxin treatment of occupational and focal hand dystonia.Botulinum toxins in neurological disease.Botulinum toxin in clinical practicePatient-based outcomes of cervical dystonia: a review of rating scales.Botulinum toxin in children with cerebral palsy.Botulinum toxin-physiology and applications in head and neck disorders.Treatment of cervical dystonia with botulinum toxins.Botulinum toxin therapy of laryngeal muscle hyperactivity syndromes: comparing different botulinum toxin preparations.Management of spasticity in adults: practical application of botulinum toxin.Clinical use of non-A botulinum toxins: botulinum toxin type B.Long term effects of intra-articular botulinum toxin A for refractory joint pain.Comparing the Effect of Botulinum Toxin Type B Injection at Different Dosages for Patient with Drooling due to Brain Lesion.Botulinum toxin for the management of bladder dysfunction.Development of the Comprehensive Cervical Dystonia Rating Scale: MethodologyBotulinum toxin: description of injection techniques and examination of controversies surrounding toxin diffusion.
P2860
Q24185766-D84EFD7D-9DCB-46D8-93E0-982196626709Q24245929-EDFD458B-13A8-4320-A7D7-A1197D97AF51Q24634441-6615C0EA-1F10-4172-B56F-B8EFD188E0E9Q26766284-1DCFA295-4050-4184-8BA9-9A7130C975FAQ26775670-F2DE7E42-38CE-45AF-84B4-3AAE2CBF9E9DQ26824771-01D8A90E-9FDD-4367-975C-515B02E5D242Q30465848-D14E706F-4C29-43CA-AF52-B9D921476433Q30566734-8A0727F6-903D-4C09-86BA-D05C7EF92345Q30736752-4ECA9E2C-1CA9-4B85-B1A4-696F99DABD4CQ30913570-7A0DBEAD-AC3B-4ACD-84BD-82AE09B880ABQ31069022-CF907D56-1EE0-4323-A05C-45D94A405948Q31085876-7729C134-8BCE-42F8-B794-2BAA92965AEFQ32064742-24E3C32F-01C4-4D50-B894-8A5F801085D0Q33738769-3EC3CD6E-A3C4-4F38-BA5B-C21FC4A0F684Q33768467-0A25DA3A-154C-49AF-965E-052B6B088569Q33793263-B0DED64F-5F2C-4FA9-AA3A-6ACFB5DA4AA0Q33938316-58CBE025-69D0-4640-B3F0-9B071F852403Q34041378-92F4DFA9-9865-4891-9414-7016F0E67D37Q34326421-37748794-F1B5-450A-873F-5EDB7C71FF86Q34393230-9A3CE475-040E-4B02-B226-AF34F4AEEE09Q34406870-FC43C026-CFAC-41E6-BC1B-CAF0BE41FC69Q34481941-575316A7-C6CC-4110-B811-5814963E197EQ34566502-43C72C1F-1B00-4ABE-B0A0-008EB064BAD9Q35693989-D6E80293-4B5B-4AE2-994B-624FDDB20FE2Q35693995-6B7F0CD6-774E-44F3-BECC-77B3E5D731F0Q35693998-5D48D613-9E3A-43A2-AC13-AD7BEB64E135Q35759634-B03CC506-7306-43FB-9417-7DC2BDFD4401Q35807826-3EE02781-FB74-4F0F-B271-C54A6C67FF5DQ35889922-4C070194-322F-4D65-B345-610022C7ADE9Q35998686-0E3C905F-24DE-4BFB-B614-985ED12A5345Q36129794-DF12BE18-603A-4F5C-85D1-3528E3887B9CQ36370621-C66F822F-8AF1-4768-AA1A-D9EE0B58967DQ36370635-B839D916-4245-49FF-971E-FB9320E6F95AQ36370640-4B2FC2C9-669F-4B8D-A78E-F7BBED5F3CDAQ36511584-3AE03C6E-A690-4E6D-9757-19D7B6DD7BC9Q36511613-28837797-CE78-4F81-BFBD-385D11A03E14Q36536684-943AB17B-33D5-4C63-92AC-36B8B37F6A4BQ36563389-F93C84E1-7427-4FA0-A22A-90C22EE6D189Q36785510-CFF6CF12-83D0-4C85-8DD2-88D3F1F0ABD1Q36938468-DE108FD2-9B7E-4F84-AC47-17A01DD5EA79
P2860
Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia.
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Safety and efficacy of NeuroBl ...... A-resistant cervical dystonia.
@ast
Safety and efficacy of NeuroBl ...... A-resistant cervical dystonia.
@en
type
label
Safety and efficacy of NeuroBl ...... A-resistant cervical dystonia.
@ast
Safety and efficacy of NeuroBl ...... A-resistant cervical dystonia.
@en
prefLabel
Safety and efficacy of NeuroBl ...... A-resistant cervical dystonia.
@ast
Safety and efficacy of NeuroBl ...... A-resistant cervical dystonia.
@en
P2093
P356
P1433
P1476
Safety and efficacy of NeuroBl ...... A-resistant cervical dystonia.
@en
P2093
A Willmer-Hulme
C L Comella
J D Wallace
J J Murray
J Jankovic
P304
P356
10.1212/WNL.53.7.1431
P407
P577
1999-10-01T00:00:00Z